Zobrazeno 1 - 10
of 20
pro vyhledávání: '"José-Luis Fírvida Pérez"'
Autor:
Jesús García-Mata, María C Areses, Soledad Cameselle-García, Jesús Daniel Fernández de Castro, Juan Mosquera-Reboredo, José Luis Fírvida Pérez
Publikováno v:
World Journal of Clinical Cases
Background Primary malignant melanoma of the biliary tract (MBT) is a rare condition whose diagnosis requires excluding a primary origin in another location. This paper reviews the most important characteristics of MBT cases published in the literatu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10f5052ed37dc554717cd7f6e1099a0d
https://doi.org/10.12998/wjcc.v7.i16.2302
https://doi.org/10.12998/wjcc.v7.i16.2302
Autor:
Rocio Vilchez Simo, Maria Carmen Areses Manrique, María Rosario García Campelo, Cristina Azpitarte Raposeiras, Jose Muñoz Iglesias, Joaquín Martínez, Urbano Anido Herranz, F.J. Afonso, Natalia Fernández Núñez, David Arias Ron, Begoña Campos Balea, Martin Lázaro Quintela, Juan Ruiz Bañobre, Jorge García González, Margarita Amenedo Gancedo, Lucía Santomé Couto, José Luis Fírvida Pérez, Joaquin Casal Rubio, Jesús García Mata, Guillermo Alonso-Jaudenes Curbera, Iria Carou Frieiro
Publikováno v:
Journal of geriatric oncology. 12(3)
Background Nivolumab is an anti PD1 immunotherapy drug approved for advanced Non-Small Cell Lung Cancer (NSCLC) patients who previously received at least one prior line of treatment. Older patients are often not represented in clinical trials and dru
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc8f0359c9eb9f002de01c36c87004c8
https://pubmed.ncbi.nlm.nih.gov/33357975
https://pubmed.ncbi.nlm.nih.gov/33357975
Autor:
Juan Ruiz-Bañobre, José Luis Fírvida Pérez, N. Fernández-Núñez, L. Crama, Martín Lázaro-Quintela, Francisco J. Afonso-Afonso, Pedro Ruiz-Gracia, Jorge García-González, Diego Pérez Parente, Margarita Amenedo-Gancedo, María Del Carmen Areses-Manrique, Lucía Santomé-Couto, Luis León-Mateos, Begoña Campos-Balea, Joaquín Casal-Rubio
Publikováno v:
Journal of Clinical Medicine, Vol 9, Iss 2093, p 2093 (2020)
Journal of Clinical Medicine
Journal of Clinical Medicine
The combination of programmed cell death-1 (PD-1)/programmed death ligand-1 (PD-L1) inhibitors with chemotherapy has emerged as a promising therapeutic option for advanced non-small-cell lung cancer (NSCLC). The aim of this meta-analysis was to evalu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d982e59727b6939f5f52526f8a8378eb
https://www.mdpi.com/2077-0383/9/7/2093
https://www.mdpi.com/2077-0383/9/7/2093
Autor:
Natalia Fernández Núñez, Martin Lázaro Quintela, Iria Carou Frieiro, Joaquin Mosquera Martinez, Margarita Amenedo Gancedo, Joaquin Casal Rubio, Jose Muñoz Iglesias, Alexandra Sabela Cortegoso mosquera, Rocio Vilchez Simo, Urbano Anido Herranz, Jesús García Mata, Lucía Santomé Couto, Begoña Campos Balea, Mª Carmen Areses Manrique, Jorge García González, Mª Rosario García Campelo, Guillermo Alonso-Jaudenes Curbera, José Luis Fírvida Pérez, Cristina Azpitarte Raposeiras, F.J. Afonso
Publikováno v:
Translational Lung Cancer Research. 7:404-415
Background Recently, immunotherapy has changed the standard of treatment in non-small cell lung cancer (NSCLC). Outside clinical trials, data of real life is lacking. This is an observational study that represents the real world experience with nivol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0cc7bb30d30b4aba37c3cf312d55b53a
https://doi.org/10.21037/tlcr.2018.04.03
https://doi.org/10.21037/tlcr.2018.04.03
Autor:
Alexandra Giraldo-Marín, Oliver Higuera, Luis Cabezón-Gutiérrez, Almudena Sanz-Yagüe, Rodolfo Chicas Sett, Gala Serrano Bermúdez, Pilar Togores, Ignacio Delgado, Francisco Javier García Navalón, Carmen Beato, Pedro Sánchez Mauriño, Ibone Huerta-González, Antonio Javier Jiménez-López, Anna Librán-Oriol, Manuel Cobo Dols, Begoña Soler, Diana Moreno, Alfredo Paredes Lario, José-Luis Fírvida Pérez, Isabel Blancas
Publikováno v:
Journal of Clinical Oncology. 38:e24155-e24155
e24155 Background: Naloxegol is a peripherally acting, µ-opioid receptor antagonist for treatment of opioid-induced constipation (OIC). The main objective of this study was to analyze the efficacy and safety of naloxegol in patients with cancer in a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dbcdbf901d28fc1bb232015fb4397d05
https://doi.org/10.1200/jco.2020.38.15_suppl.e24155
https://doi.org/10.1200/jco.2020.38.15_suppl.e24155
Publikováno v:
The European Physical Journal Plus. 133
Nowadays, radioactive materials are widely used in medicine, agriculture, industry and scientific research. This implies a growing accessibility and their potential use for criminal or terrorist purposes, i.e. as Radioactive Dispersion Device (RDD) o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aaf17a2698a91896def643f93a06dbce
https://doi.org/10.1140/epjp/i2018-12148-1
https://doi.org/10.1140/epjp/i2018-12148-1
Autor:
José Luis Fírvida Pérez, Karel Mazanec, Jose Antonio Domínguez, Luis Jesús Amigo, Laura Pascual, Marta Fernández, Javier Quiñones
Publikováno v:
Enhancing CBRNE Safety & Security: Proceedings of the SICC 2017 Conference ISBN: 9783319917900
Nowadays, the threat of a terrorist attack with CBRNE (chemical, biological, radiological, nuclear, and explosive) agents is very real, as can be seen in the increasing appearance of news related to the use of CWA (chemical warfare agent) in criminal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::74c569d970e8a86c757bf576413dffd9
https://doi.org/10.1007/978-3-319-91791-7_12
https://doi.org/10.1007/978-3-319-91791-7_12
Autor:
F.J. Afonso, Nazaret Quiroga Veiga, Cristina Azpitarte Raposeiras, Joaquin Casal Rubio, Margarita Amenedo, Lucía Santomé, Rafael López, Maria Carmen Areses Manrique, Rosario Garcia Campelo, Gerardo Huidobro Vence, Joaquín Martínez, Guillermo Alonso-Jaudenes Curbera, Natalia Fernández Núñez, Urbano Anido Herranz, Rocio Vilchez Simo, Alexandra Cortegoso, Sergio Vázquez Estévez, Jesús García Mata, Juan Ruiz Bañobre, José Luis Fírvida Pérez
Publikováno v:
Journal of Clinical Oncology. 37:e20645-e20645
e20645 Background: The lung immune prognostic index (LIPI) has been proposed as a new biomarker to select advanced non-small cell lung cancer (NSCLC) patients for anti-programmed cell death-1 or programmed death ligand 1 therapy. In this study, we in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aa744ffa139bdae4677d0bc712ca0139
https://doi.org/10.1200/jco.2019.37.15_suppl.e20645
https://doi.org/10.1200/jco.2019.37.15_suppl.e20645
Publikováno v:
RUNA. Repositorio da Consellería de Sanidade e Sergas
Servizo Galego de Saúde (SERGAS)
Servizo Galego de Saúde (SERGAS)
Resumen El cancer de pulmon (CP) es un grave problema sanitario debido a su elevada incidencia y mortalidad. La cirugia es la mas eficaz de las estrategias terapeuticas en este tipo de tumor, pero en los ultimos anos se estan investigando nuevos farm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f0ef2afa95f268e9adfe5821112213b5
https://doi.org/10.1016/j.arbres.2012.03.007
https://doi.org/10.1016/j.arbres.2012.03.007
Publikováno v:
Archivos de Bronconeumología (English Edition). 48:367-371
Lung cancer (LC) is a serious health problem due to its high incidence and mortality. Surgery is the most effective therapeutic strategy in this type of tumor, but in recent years new drugs are being investigated that target specific components of th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e3ca584f57e702d5748ac0d5325f5ddc
https://doi.org/10.1016/j.arbr.2012.07.003
https://doi.org/10.1016/j.arbr.2012.07.003